HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits

Life Sciences

Volumn 62, Issue 12, 1998, Pages 1055-1063

  Asami, Yumiko ^a   Yamagishi, Izumi ^a   Murakami, Shigeru ^a   Araki, Hiroaki ^a   Tsuchida, Katsuharu ^a   Higuchi, Shohei ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

ACAT inhibitor; Atherosclerosis; Cholesterol; HL 004

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; N (2,6 DIISOPROPYLPHENYL)TETRADECYLTHIOACETAMIDE; NEW DRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; HYPERLIPIDEMIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; THORACIC AORTA;

ACETANILIDES; ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, THORACIC; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, DIETARY; DISEASE PROGRESSION; EATING; ENZYME INHIBITORS; LIPIDS; LIVER; MALE; RABBITS; STEROL O-ACYLTRANSFERASE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032512695     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00028-9     Document Type: Article

References (22)

1. 1. A.A. SPECTOR, S.N. MATHUR and T.L. KADUCE, Prog. Lipid Res. 18 31-53 (1979).
2. 2. S.B. CLARK, and A.M. TERCYAK, J. Lipid Res. 25 148-159 (1984).
3. 3. F.J. FIELD, A.D. COOPER and S.K. ERICKSON, Gastroenterology . 83 873-880 (1982).
4. 4. J.G. HEIDER, C.E. PICKENS and L.A. KELLY, J. Lipd Res. 24 1127-1134 (1983).
5. 5. T.P. CARR, R.L. HAMILTON Jr., and L.L. RUDEL, J. Lipid Res. 36 25-36 (1995).
6. 6. C.A. DREVON, S.C. ENGELHORN and D. STEINBERG, J. Lipid Res. 21 1065-1071 (1980).
7. 7. K.M. CIANFLONE, Z. YASRUEL, M.A. RODRIGUEZ, D. VAS and A.D. SNIDERMAN, J. Lipid Res. 31 2045-2055 (1990).
8. 8. P.I. BRECHER, and A.V. CHOBANIAN, Circ. Res. 35 692-701 (1974).
9. 9. S. HASHIMOTO, S. DAYTON, R.B. ALFIN-SLATER, P.T. BUI, N. BAKER and L. WILSON, Cir. Res. 35 176-183 (1974).
10. 10. F.P. BELL, R.B. GAMMILL, and L.C. St.JOHN, Atherosclerosis. 92 115-122 (1992).
11. 11. B.R. KRAUSE, M. ANDERSON, C.L. BISGAIER, T. BOCAN, R. BOUSLEY, P. DEHART, A. ESSENBURG, K. HAMELEHLE, R. HOMAN, K. KIEFT, W. McNALLY, R. STANFIELD and R.S. NEWTON, J. Lipid Res. 34 279-294 (1993).
12. 12. H. TANAKA, I. OHTSUKA, M. KOGUSHI, T. KIMURA, T. FUJIMORI, T. SAEKI, K. HAYASHI, H. KOBAYASHI, T. YAMADA, H. HIYOSHI and I. SAITO, Atherosclerosis 107 187-201 (1994).
13. 13. Y. SUGIYAMA, E. ISHIKAWA, H. ODAKA, N. MIKI, H. TAWADA, and H. IKEDA, Atherosclerosis 113 71-78 (1995).
14. 14. Y. SAKUMA, H. HAGIHARA, K. OHNE, A. NAGAYOSHI, S. MUTOH, Y. ITO, Y. NOTSU and M. OKUHARA, Jpn. J. Pharmacol. 70 35-41 (1996).
15. 15. M. KOGUSHI, H. TANAKA, H. KOBAYASHI, T. YAMADA, I. OHTSUKA, T. KIMURA and I. SAITO, Jpn. J. Pharmacol. 68 191-199 (1995).
16. 16. S. MURAKAMI, H. ARAKI, S. OTOMO, Y. NARA and Y. YAMORI, Life Sci. 56 509-520 (1995).
17. 17. J.M. DIETSCHY, Engl. J. Med. 282 1241-1249 (1970).
18. 18. P. HELGERUD, K. SAAREM, and K.R. NORUM, J. Lipid Res. 22 271-277 (1981).
19. 19. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
20. 20. Y. HATA, H. SHIGEMATSU, M. TSUSHIMA and K. AIHARA, Atherosclerosis 29 251-258 (1978).
21. 21. S. MURAKAMI, I. YAMAGISHI, Y. ASAMI, M. SATO, and K. TOMISAWA, Cellular and Molecular Biology. 42 865-872 (1996).
22. 22. T. YANAGITA, K. SONDA, K. YAMAMOTO, H. YOTSUMOTO, J. H. NUNEZ and S. MURAKAMI, Current Therapeutic Research. 56 787-795 (1995).